These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 25326709)

  • 1. Effect of atorvastatin on the expression of gamma-glutamyl transferase in aortic atherosclerotic plaques of apolipoprotein E-knockout mice.
    Li G; Wu XW; Lu WH; Ai R; Chen F; Tang ZZ
    BMC Cardiovasc Disord; 2014 Oct; 14():145. PubMed ID: 25326709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atorvastatin inhibits the 5-lipoxygenase pathway and expression of CCL3 to alleviate atherosclerotic lesions in atherosclerotic ApoE knockout mice.
    Yang LX; Heng XH; Guo RW; Si YK; Qi F; Zhou XB
    J Cardiovasc Pharmacol; 2013 Aug; 62(2):205-11. PubMed ID: 23615158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Near-infrared fluorescence imaging of murine atherosclerosis using an oxidized low density lipoprotein-targeted fluorochrome.
    Lu T; Wen S; Cui Y; Ju SH; Li KC; Teng GJ
    Int J Cardiovasc Imaging; 2014 Jan; 30(1):221-31. PubMed ID: 24170262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDOC and atorvastatin have potential antiinflammatory effects in vascular endothelium of apoE-/- mouse model of atherosclerosis.
    Nachtigal P; Pospisilova N; Pospechova K; Jamborova G; Kopecky M; Jaynes R; Briestensky J; Santar I; Smahelova A; Solichova D; Zdansky P; Semecky V
    Life Sci; 2006 Mar; 78(17):1983-9. PubMed ID: 16305803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis.
    Nahrendorf M; Keliher E; Panizzi P; Zhang H; Hembrador S; Figueiredo JL; Aikawa E; Kelly K; Libby P; Weissleder R
    JACC Cardiovasc Imaging; 2009 Oct; 2(10):1213-22. PubMed ID: 19833312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atorvastatin has distinct effects on endothelial markers in different mouse models of atherosclerosis.
    Nachtigal P; Jamborova G; Pospisilova N; Pospechova K; Solichova D; Zdansky P; Semecky V
    J Pharm Pharm Sci; 2006; 9(2):222-30. PubMed ID: 16959191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins' Withdrawal Induces Atherosclerotic Plaque Destabilization in Animal Model-A "Rebound" Stimulation of Inflammation.
    Stasinopoulou M; Kadoglou NPE; Christodoulou E; Paronis E; Kostomitsopoulos NG; Valsami G; Liapis CD; Kakisis J
    J Cardiovasc Pharmacol Ther; 2019 Jul; 24(4):377-386. PubMed ID: 30905179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions.
    Yoshii T; Iwai M; Li Z; Chen R; Ide A; Fukunaga S; Oshita A; Mogi M; Higaki J; Horiuchi M
    Hypertens Res; 2006 Jun; 29(6):457-66. PubMed ID: 16940709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The complementary effects of atorvastatin and exercise treatment on the composition and stability of the atherosclerotic plaques in ApoE knockout mice.
    Moustardas P; Kadoglou NP; Katsimpoulas M; Kapelouzou A; Kostomitsopoulos N; Karayannacos PE; Kostakis A; Liapis CD
    PLoS One; 2014; 9(9):e108240. PubMed ID: 25264981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulations of CD36 and Calpain-1, Inflammation, and Atherosclerosis by Simvastatin in Apolipoprotein E Knockout Mice.
    Yin M; Liu Q; Yu L; Yang Y; Lu M; Wang H; Luo D; Rong X; Tang F; Guo J
    J Vasc Res; 2017; 54(3):123-130. PubMed ID: 28448973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmalogen modulation attenuates atherosclerosis in ApoE- and ApoE/GPx1-deficient mice.
    Rasmiena AA; Barlow CK; Stefanovic N; Huynh K; Tan R; Sharma A; Tull D; de Haan JB; Meikle PJ
    Atherosclerosis; 2015 Dec; 243(2):598-608. PubMed ID: 26545014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparanase promotes the onset and progression of atherosclerosis in apolipoprotein E gene knockout mice.
    Nguyen TK; Paone S; Baxter AA; Mayfosh AJ; Phan TK; Chan E; Peter K; Poon IKH; Thomas SR; Hulett MD
    Atherosclerosis; 2024 May; 392():117519. PubMed ID: 38581737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice.
    Nachtigal P; Pospisilova N; Jamborova G; Pospechova K; Solichova D; Andrys C; Zdansky P; Micuda S; Semecky V
    Life Sci; 2008 Mar; 82(13-14):708-17. PubMed ID: 18289605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy with cilostazol and pravastatin improves antiatherogenic effects in low-density lipoprotein receptor knockout mice.
    Park KY; Heo TH
    Cardiovasc Ther; 2018 Dec; 36(6):e12476. PubMed ID: 30378752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atorvastatin inhibits plaque development and adventitial neovascularization in ApoE deficient mice independent of plasma cholesterol levels.
    Bot I; Jukema JW; Lankhuizen IM; van Berkel TJ; Biessen EA
    Atherosclerosis; 2011 Feb; 214(2):295-300. PubMed ID: 21130458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation contributes to the atherogenic role of intermittent hypoxia in apolipoprotein-E knock out mice.
    Arnaud C; Poulain L; Lévy P; Dematteis M
    Atherosclerosis; 2011 Dec; 219(2):425-31. PubMed ID: 21917260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanism of total flavonoids of Ziziphora clinopodioides in improving atherosclerosis by regulating PI3K/Akt/mTOR pathway].
    Ma XY; Zhao HR; Qiao HL; Zeng YC; Zhang XM
    Zhongguo Zhong Yao Za Zhi; 2023 Jan; 48(2):465-471. PubMed ID: 36725236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1 at the early stages of atherosclerosis in a rat model.
    Fotis L; Agrogiannis G; Vlachos IS; Pantopoulou A; Margoni A; Kostaki M; Verikokos C; Tzivras D; Mikhailidis DP; Perrea D
    In Vivo; 2012; 26(2):243-50. PubMed ID: 22351665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of endothelial NF-κB signaling attenuates chronic intermittent hypoxia-induced atherosclerosis in mice.
    Song D; Fang G; Mao SZ; Ye X; Liu G; Miller EJ; Greenberg H; Liu SF
    Atherosclerosis; 2018 Mar; 270():68-75. PubMed ID: 29407890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atorvastatin, etidronate, or both in patients at high risk for atherosclerotic aortic plaques: a randomized, controlled trial.
    Kawahara T; Nishikawa M; Kawahara C; Inazu T; Sakai K; Suzuki G
    Circulation; 2013 Jun; 127(23):2327-35. PubMed ID: 23658438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.